{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:37:46Z","timestamp":1794692266960,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["CRC-2022-00575"],"award-info":[{"award-number":["CRC-2022-00575"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","award":["514681"],"award-info":[{"award-number":["514681"]}],"id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJH-185722"],"award-info":[{"award-number":["PJH-185722"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-192011"],"award-info":[{"award-number":["PJT-192011"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-195669"],"award-info":[{"award-number":["PJT-195669"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"DOI":"10.1038\/s41587-026-03109-0","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:08:35Z","timestamp":1777367315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery"],"prefix":"10.1038","author":[{"given":"Muye","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8888-5189","authenticated-orcid":false,"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5105-102X","authenticated-orcid":false,"given":"Jingan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Savguira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6888-1811","authenticated-orcid":false,"given":"Breanna","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick Xing Ze","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6841-6924","authenticated-orcid":false,"given":"Songtao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4635-1905","authenticated-orcid":false,"given":"David","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel","family":"Eileen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-9143","authenticated-orcid":false,"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"3109_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3109_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3109_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"3109_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41564-021-01053-0","volume":"7","author":"S Nasreen","year":"2022","unstructured":"Nasreen, S. et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat. Microbiol. 7, 379\u2013385 (2022).","journal-title":"Nat. Microbiol."},{"key":"3109_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"3109_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466337","volume":"15","author":"O Vasileva","year":"2024","unstructured":"Vasileva, O., Zaborova, O., Shmykov, B., Ivanov, R. & Reshetnikov, V. Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Front. Pharmacol. 15, 1466337 (2024).","journal-title":"Front. Pharmacol."},{"key":"3109_CR7","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","volume":"33","author":"A Wittrup","year":"2015","unstructured":"Wittrup, A. et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33, 870\u2013876 (2015).","journal-title":"Nat. Biotechnol."},{"key":"3109_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4398","volume":"7","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).","journal-title":"Sci. Adv."},{"key":"3109_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116271119","volume":"119","author":"M Qiu","year":"2022","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3109_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101436","volume":"33","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat, M., Bremmell, K. E. & Prestidge, C. A. Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol. Ther. Methods Clin. Dev. 33, 101436 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3109_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357\u20131364 (2010).","journal-title":"Mol. Ther."},{"key":"3109_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/nat.2018.0734","volume":"28","author":"R Jain","year":"2018","unstructured":"Jain, R. et al. MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct. Nucleic Acid Ther. 28, 285\u2013296 (2018).","journal-title":"Nucleic Acid Ther."},{"key":"3109_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906128","volume":"32","author":"S Ramishetti","year":"2020","unstructured":"Ramishetti, S. et al. A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes. Adv. Mater. 32, e1906128 (2020).","journal-title":"Adv. Mater."},{"key":"3109_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309472120","volume":"120","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc. Natl Acad. Sci. USA 120, e2309472120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3109_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"3109_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45537-z","volume":"15","author":"X Han","year":"2024","unstructured":"Han, X. et al. In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors. Nat. Commun. 15, 1762 (2024).","journal-title":"Nat. Commun."},{"key":"3109_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-025-01516-z","volume":"8","author":"\u00c1 Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a, \u00c1 et al. Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs. Commun. Chem. 8, 116 (2025).","journal-title":"Commun. Chem."},{"key":"3109_CR18","doi-asserted-by":"publisher","first-page":"29045","DOI":"10.1021\/acsnano.4c10154","volume":"18","author":"I Isaac","year":"2024","unstructured":"Isaac, I. et al. Tetrahydropyrimidine ionizable lipids for efficient mRNA delivery. ACS Nano 18, 29045\u201329058 (2024).","journal-title":"ACS Nano"},{"key":"3109_CR19","doi-asserted-by":"publisher","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","volume":"18","author":"AG Hamilton","year":"2024","unstructured":"Hamilton, A. G. et al. High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route. ACS Nano 18, 16151\u201316165 (2024).","journal-title":"ACS Nano"},{"key":"3109_CR20","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"3109_CR21","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","volume":"19","author":"HH Ly","year":"2022","unstructured":"Ly, H. H., Daniel, S., Soriano, S. K. V., Kis, Z. & Blakney, A. K. Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach. Mol. Pharm. 19, 1892\u20131905 (2022).","journal-title":"Mol. Pharm."},{"key":"3109_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50093-7","volume":"15","author":"K Su","year":"2024","unstructured":"Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat. Commun. 15, 5659 (2024).","journal-title":"Nat. Commun."},{"key":"3109_CR23","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653\u20131663 (2025).","journal-title":"Nat. Mater."},{"key":"3109_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-019-0351-1","volume":"3","author":"G Yamankurt","year":"2019","unstructured":"Yamankurt, G. et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat. Biomed. Eng. 3, 318\u2013327 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"3109_CR25","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. LUMI-lab: a foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery. Cell 189, 1620\u20131635 (2026).","DOI":"10.1016\/j.cell.2026.01.012"},{"key":"3109_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50619-z","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).","journal-title":"Nat. Commun."},{"key":"3109_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55072-6","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery. Nat. Commun. 15, 10804 (2024).","journal-title":"Nat. Commun."},{"key":"3109_CR28","doi-asserted-by":"crossref","unstructured":"Witten, J. et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat. Biotechnol. 43, 1790\u20131799 (2025).","DOI":"10.1038\/s41587-024-02490-y"},{"key":"3109_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002\u20131008 (2024).","journal-title":"Nat. Mater."},{"key":"3109_CR30","doi-asserted-by":"crossref","unstructured":"Sengprasert, P., Kamenkit, O., Tanavalee, A. & Reantragoon, R. The immunological facets of chondrocytes in osteoarthritis: a narrative review. J. Rheumatol. 51, 13\u201324 (2024).","DOI":"10.3899\/jrheum.2023-0816"},{"key":"3109_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ncprheum0534","volume":"3","author":"T Aigner","year":"2007","unstructured":"Aigner, T., S\u00f6der, S., Gebhard, P. M., McAlinden, A. & Haag, J. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis\u2013structure, chaos and senescence. Nat. Clin. Pract. Rheumatol. 3, 391\u2013399 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"3109_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101249","volume":"66","author":"L Zheng","year":"2021","unstructured":"Zheng, L., Zhang, Z., Sheng, P. & Mobasheri, A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res. Rev. 66, 101249 (2021).","journal-title":"Ageing Res. Rev."},{"key":"3109_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.gt.3301086","volume":"7","author":"H Madry","year":"2000","unstructured":"Madry, H. & Trippel, S. B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7, 286\u2013291 (2000).","journal-title":"Gene Ther."},{"key":"3109_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/107632702753725003","volume":"8","author":"A Hamm","year":"2002","unstructured":"Hamm, A., Krott, N., Breibach, I., Blindt, R. & Bosserhoff, A. K. Efficient transfection method for primary cells. Tissue Eng. 8, 235\u2013245 (2002).","journal-title":"Tissue Eng."},{"key":"3109_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbad014","volume":"6","author":"X Li","year":"2023","unstructured":"Li, X., Shen, L., Deng, Z. & Huang, Z. New treatment for osteoarthritis: gene therapy. Precis. Clin. Med. 6, pbad014 (2023).","journal-title":"Precis. Clin. Med."},{"key":"3109_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s42256-022-00447-x","volume":"4","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Wang, J., Cao, Z. & Barati Farimani, A. Molecular contrastive learning of representations via graph neural networks. Nat. Mach. Intell. 4, 279\u2013287 (2022).","journal-title":"Nat. Mach. Intell."},{"key":"3109_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki, H., Tian, Y.-S., Kawashita, N. & Takagi, T. Mordred: a molecular descriptor calculator. J. Cheminform. 10, 4 (2018).","journal-title":"J. Cheminform."},{"key":"3109_CR38","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","DOI":"10.21105\/joss.00861"},{"key":"3109_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s004180050441","volume":"113","author":"W Schwab","year":"2000","unstructured":"Schwab, W. et al. Characterization of caveolins from human knee joint cartilage: expression of caveolin-1, -2, and -3 in chondrocytes and association with integrin \u03b21. Histochem. Cell Biol. 113, 221\u2013225 (2000).","journal-title":"Histochem. Cell Biol."},{"key":"3109_CR40","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1096\/fj.11-184861","volume":"25","author":"P Wang","year":"2011","unstructured":"Wang, P., Zhu, F., Tong, Z. & Konstantopoulos, K. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. FASEB J. 25, 3401\u20133415 (2011).","journal-title":"FASEB J."},{"key":"3109_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan, F. et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct. Target. Ther. 10, 93 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3109_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","volume":"10","author":"HH Gustafson","year":"2015","unstructured":"Gustafson, H. H., Holt-Casper, D., Grainger, D. W. & Ghandehari, H. Nanoparticle UPTAKE: THE PHAGOCYTE PROBLEM. Nano Today 10, 487\u2013510 (2015).","journal-title":"Nano Today"},{"key":"3109_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"3109_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt.3806","volume":"35","author":"BT Staahl","year":"2017","unstructured":"Staahl, B. T. et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat. Biotechnol. 35, 431\u2013434 (2017).","journal-title":"Nat. Biotechnol."},{"key":"3109_CR45","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"3109_CR46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ymthe.2023.02.009","volume":"31","author":"SY Yu","year":"2023","unstructured":"Yu, S. Y. et al. A luciferase reporter mouse model to optimize in vivo gene editing validated by lipid nanoparticle delivery of adenine base editors. Mol. Ther. 31, 1159\u20131166 (2023).","journal-title":"Mol. Ther."},{"key":"3109_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41551-021-00780-3","volume":"5","author":"SK Bedingfield","year":"2021","unstructured":"Bedingfield, S. K. et al. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat. Biomed. Eng. 5, 1069\u20131083 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"3109_CR48","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41551-025-01376-x","volume":"9","author":"JM Colazo","year":"2025","unstructured":"Colazo, J. M. et al. siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigs. Nat. Biomed. Eng. 9, 1366\u20131383 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"3109_CR49","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.1021\/acsnano.1c04005","volume":"15","author":"SK Bedingfield","year":"2021","unstructured":"Bedingfield, S. K. et al. Top-down fabricated microPlates for prolonged, intra-articular matrix metalloproteinase 13 siRNA nanocarrier delivery to reduce post-traumatic osteoarthritis. ACS Nano 15, 14475\u201314491 (2021).","journal-title":"ACS Nano"},{"key":"3109_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041742","volume":"22","author":"Q Hu","year":"2021","unstructured":"Hu, Q. & Ecker, M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int. J. Mol. Sci. 22, 1742 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"3109_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/ar4133","volume":"15","author":"M Wang","year":"2013","unstructured":"Wang, M. et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15, R5 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"3109_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138920108783497659","volume":"9","author":"H Takaishi","year":"2008","unstructured":"Takaishi, H., Kimura, T., Dalal, S., Okada, Y. & D\u2019Armiento, J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 9, 47\u201354 (2008).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"3109_CR53","doi-asserted-by":"publisher","unstructured":"Zenhausern, R. et al. Lipid nanoparticle screening in nonhuman primates with minimal loss of life. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02711-y (2025).","DOI":"10.1038\/s41587-025-02711-y"},{"key":"3109_CR54","doi-asserted-by":"crossref","unstructured":"Kim, H. et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nat. Biotechnol. 43, 1813\u20131820 (2025).","DOI":"10.1038\/s41587-024-02470-2"},{"key":"3109_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."},{"key":"3109_CR56","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nprot.2008.95","volume":"3","author":"M Gosset","year":"2008","unstructured":"Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253\u20131260 (2008).","journal-title":"Nat. Protoc."},{"key":"3109_CR57","doi-asserted-by":"crossref","unstructured":"Saeki, N. & Imai, Y. Isolation and culture of primary synovial macrophages and fibroblasts from murine arthritis tissue. J. Vis. Exp. 192, e65196 (2023).","DOI":"10.3791\/65196"},{"key":"3109_CR58","doi-asserted-by":"publisher","unstructured":"Li, B. & Li, G. bowenli-lab\/MOLEA: v1.0.0. Zenodo https:\/\/doi.org\/10.5281\/zenodo.18943783 (2026).","DOI":"10.5281\/zenodo.18943783"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03109-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:08:43Z","timestamp":1777367323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":58,"alternative-id":["3109"],"URL":"https:\/\/doi.org\/10.1038\/s41587-026-03109-0","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}